Innoviva (NASDAQ: INVA) reported Q2 EPS of $0.77, $0.31 better than the analyst estimate of $0.46. Revenue for the quarter came in at $100.28 million versus the consensus estimate of $90.59 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.